Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,000
Closed -$1.36K 3701
2025
Q2
$1.36K Hold
3,000
﹤0.01% 3129
2025
Q1
$1.22K Hold
3,000
﹤0.01% 3080
2024
Q4
$1.99K Hold
3,000
﹤0.01% 2974
2024
Q3
$2.55K Hold
3,000
﹤0.01% 2824
2024
Q2
$2K Hold
3,000
﹤0.01% 2812
2024
Q1
$3.9K Sell
3,000
-830
-22% -$870 ﹤0.01% 2600
2023
Q4
$2.19K Hold
3,830
﹤0.01% 2778
2023
Q3
$2.89K Hold
3,830
﹤0.01% 2702
2023
Q2
$2.8K Sell
3,830
-96
-2% -$89 ﹤0.01% 2648
2023
Q1
$2.97K Hold
3,926
﹤0.01% 2610
2022
Q4
$3.77K Buy
3,926
+25
+0.6% +$35 ﹤0.01% 2448
2022
Q3
$9K Hold
3,901
﹤0.01% 2053
2022
Q2
$14K Buy
3,901
+3,000
+333% +$11.2K ﹤0.01% 1853
2022
Q1
$4K Sell
901
-566
-39% -$2.87K ﹤0.01% 2416
2021
Q4
$9K Sell
1,467
-204
-12% -$1.39K ﹤0.01% 2176
2021
Q3
$13K Hold
1,671
﹤0.01% 1962
2021
Q2
$13K Hold
1,671
﹤0.01% 1914
2021
Q1
$10K Buy
1,671
+341
+26% +$2.62K ﹤0.01% 1938
2020
Q4
$8K Buy
1,330
+350
+36% +$2.23K ﹤0.01% 1895
2020
Q3
$7K Buy
980
+259
+36% +$2.31K ﹤0.01% 1916
2020
Q2
$6K Sell
721
-1,680
-70% -$4.83K ﹤0.01% 1925
2020
Q1
$4K Sell
2,401
-8,000
-77% -$10.2K ﹤0.01% 1985
2019
Q4
$4K Buy
10,401
+3,500
+51% +$1.16K ﹤0.01% 2064
2019
Q3
$2K Buy
+6,901
New +$4.51K ﹤0.01% 2211

Other funds holding VXRT

Parallel Advisors's VXRT Position: Q3 2025 in Review

Parallel Advisors sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 3,000 shares — an estimated $1.36K sold.

Parallel Advisors first reported a position in VXRT in Q3 2019 and held it in 24 quarters. The position peaked at $14K in Q2 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Parallel Advisors reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Parallel Advisors sold 3,000 Vaxart shares in Q3 2025, an estimated $1.36K.
  • Parallel Advisors first reported a position in Vaxart in Q3 2019 and held it in 24 quarters.
  • Parallel Advisors's Vaxart position peaked at $14K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.